Hemotune AG announced that it has received CHF 5.1 million in funding from Green Cross Medical Science Corporation, ZKB Start-up Finance, Occident Group AG
hemotune AG announced that it has raised CHF 5.1 million in a round of funding led by new investor Occident Group AG on July 23, 2020. The agreement was singed. The transaction included participation from new investors Green Cross Medical Science Corporation (KOSDAQ:A142280) and ZKB Start-up Finance. The company has raised CHF 10 million in funding till date.